Navigation Links
Suppressing A Girls Height In Adolescence Could Lead to Fertility Problems

Latest research shows that giving adolescent girls estrogen treatments to keep them from getting too tall could leads to fertility // problems later on in life . Estrogen is thought to limit height by altering long bone development.

The study involved 780 women who had been assessed for estrogen therapy as girls and completed a fertility survey later in life. About half had actually been treated with estrogen, and the other half was not treated. Overall, women who had been given estrogen as girls were 80-percent more likely to have been unsuccessful in achieving pregnancy after a year of trying, 80-percent more likely to have consulted with a doctor about fertility problems, and twice as likely to have taken fertility drugs. While most of these women did manage to finally become pregnant, they were 40-percent less likely to conceive in any given menstrual cycle when they were trying to become pregnant than women who didn’t take estrogen.

Researchers say their findings indicate that exposure to high-dose estrogens in adolescence is associated with impaired fertility in later life. However researchers also say that fewer girls today are receiving this treatment, as tall stature in women has now gained greater social acceptance.
'"/>




Page: 1

Related medicine news :

1. Sanyo’s Electrolysed Water Technology Effective In Suppressing Bird Fl
2. Girls Hit Tanning Booths More Than Boys
3. Vitamin D Supplement in Teenage Girls essential in Winter months
4. Vitamin D Supplement in Teenage Girls essential in Winter months
5. Girls Who Undergo Genital Mutilation Can Become Infertile
6. Boys Suffer More Mathematics Learning Disorder Than Girls
7. Sexually Abused Girls Develop Eating Disorders
8. Teenage Girls May Not Need Parents Consent For Abortion
9. AIDS More Prevalent Among Teenage Girls In The US
10. Half The Girls In UK Starve To Stay Slim
11. HIV Positive Girls Face Boycott
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/28/2017)... (PRWEB) , ... June 28, 2017 , ... ... consulting firm servicing communities throughout the greater Cincinnati metropolitan area, is teaming up ... temporary lodgings for families with children receiving treatment in nearby hospitals. , Ronald ...
(Date:6/27/2017)... London UK (PRWEB) , ... June 27, 2017 , ... ... a clinical study is whether they can trust the sponsor to pay them correctly ... vital that sponsors and CROs establish payment strategies that encourage sites to work on ...
(Date:6/27/2017)... ... , ... The Congressional Budget Office (CBO) projects that the Better Care Reconciliation ... and Affordable Care Act (ACA), would result in 22 million Americans losing their health ... More than 20 million Americans have gained health insurance under the ACA, and from ...
(Date:6/27/2017)... ... 27, 2017 , ... A January 18th article on medGadget reports ... billion by the year 2024 according to a new report. The article also notes ... from titanium. Los Angeles area clinic Beverly Hills Periodontics & Dental Implant Center says ...
(Date:6/27/2017)... New York, NY (PRWEB) , ... June 27, ... ... communications and marketing experts to contribute to an upcoming case studies guidebook. This ... or her organization. , This book will include articles, case studies and how-to’s ...
Breaking Medicine News(10 mins):
(Date:6/8/2017)... -- Less than a month ago, amateur hackers executed an ... hospital networks, in over 150 countries. The ... online extortion attempts ever recorded. With the increasing complexity ... that providers understand where the risks lie, and how ... many other very real cyber threats.  ...
(Date:6/7/2017)... GAITHERSBURG, Md. , June 7, 2017  Novavax, Inc., ... the second of two Phase 2 trials of its RSV ... women of child bearing age have been published in the ... this publication have been shared in prior scientific conferences). The ... trial in April 2014. Novavax is developing the RSV F ...
(Date:6/3/2017)... , June 3, 2017  Eli Lilly ... announced that results from the Phase 3 MONARCH ... (CDK)4 & 6 inhibitor, in combination with fulvestrant, ... with fulvestrant alone in women with hormone-receptor-positive (HR+), ... breast cancer who have relapsed or progressed after ...
Breaking Medicine Technology: